Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study – SSRN   Commentary on Twitter (thread – click for more) Preprint on Brazilian trial by @butantanoficial of Sinovac's CoronaVac, 2 weeks apart. Data for 9,823 people who had 2 doses, 12,396 after 1 dose.The P1 ("Brazilian") variant of […]

The post [Preprint] Efficacy and safety of CoronaVac in healthcare professionals in Brazil appeared first on Links Medicus.